483
Similasan AGSimilasan AG – FDA 483, Apr 4, 2023
Record Details
Similasan AG, a homeopathic manufacturer in Jonen, Switzerland, was cited for significant deficiencies in its sterile drug product manufacturing processes. Observations included inadequate sterilization process validation, insufficient investigation of out-of-specification events and product complaints, and poorly defined cleaning procedures. Additionally, the quality control unit failed to properly review and approve test procedures and released products with inaccurate test results.
View Company Profile
ID · 28e4dc28-bcbe-4843-afe5-a019433124cc
Other documents for Similasan AG
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.